- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.3390/jcm9082622
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2020
- Creator
-
Manafi-Farid, Reyhaneh
Masoumi, Fardad
Divband, Ghasemali
Saidi, Bahare
Ataeinia, Bahar
Hertel, Fabian
Schweighofer-Zwink, Gregor
Morgenroth, Agnieszka
Beheshti, Mohsen
- DOI
-
10.18154/RWTH-CONV-244677
- URN
-
urn:nbn:de:101:1-2023102001344679070894
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Manafi-Farid, Reyhaneh
- Masoumi, Fardad
- Divband, Ghasemali
- Saidi, Bahare
- Ataeinia, Bahar
- Hertel, Fabian
- Schweighofer-Zwink, Gregor
- Morgenroth, Agnieszka
- Beheshti, Mohsen
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2020
Other Objects (12)
213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
Radionuclide
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma
Comparative Study of Radionuclide Uptake Levels between Primary and Metastatic Bone Tumors
Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy
Optimal production and purification of n.c.a.143Pr as a promising palliative agent for the treatment of metastatic bone pain
Complication avoidance, rehabilitation, pain therapy and palliative care for patients with metastatic spine tumors: WFNS spine committee recommendations
Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence
An Engineered Probiotic Platform for Cancer Epitope‐Independent Targeted Radionuclide Therapy of Solid Tumors
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
Radionuclide
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma
Comparative Study of Radionuclide Uptake Levels between Primary and Metastatic Bone Tumors
Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy
Optimal production and purification of n.c.a.143Pr as a promising palliative agent for the treatment of metastatic bone pain
Complication avoidance, rehabilitation, pain therapy and palliative care for patients with metastatic spine tumors: WFNS spine committee recommendations
Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence
An Engineered Probiotic Platform for Cancer Epitope‐Independent Targeted Radionuclide Therapy of Solid Tumors
Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
Radionuclide
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma
Comparative Study of Radionuclide Uptake Levels between Primary and Metastatic Bone Tumors
Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy
Optimal production and purification of n.c.a.143Pr as a promising palliative agent for the treatment of metastatic bone pain
Complication avoidance, rehabilitation, pain therapy and palliative care for patients with metastatic spine tumors: WFNS spine committee recommendations
Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence
An Engineered Probiotic Platform for Cancer Epitope‐Independent Targeted Radionuclide Therapy of Solid Tumors